Seattle Institute For Biomedical And Clinical Research is categorized under Medical Research in Seattle, WA .
Seattle Institute For Biomedical And Clinical Research was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact at the company’s branch by writing to 1100 Olive Way # 940, Seattle, Washington WA 98101 or by phoning (206) 204-6175. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Seattle Institute For Biomedical And Clinical Research |
| Address: | 1100 Olive Way # 940, Seattle, Washington 98101 |
| Phone Number: | (206) 204-6175 |
| Website Address: | sibcr.org |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Seattle Institute For Biomedical And Clinical Research was started in 0 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact for inquiries that concern Seattle Institute For Biomedical And Clinical Research by calling the company number (206) 204-6175, as your correspondence is most welcome. Additionally, the physical location of the branch of Seattle Institute For Biomedical And Clinical Research can be found at the coordinates 47.615872,-122.33026 as well as the street address 1100 Olive Way # 940 in Seattle, Washington 98101.
For its online presence, you may visit Seattle Institute For Biomedical And Clinical Research’s website at sibcr.org and engage with its social media outlets through on Twitter and on Facebook.